Bortezomib will improve the level or outcome of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Enhanced flibanserin adverse consequences may possibly occur if coadministered with various weak CYP3A4 inhibitors. elvitegravir/cobicistat/emtricitabine/tenofovir DF raises amounts of bortezomib by affecting hepatic/intestinal enzyme CYP3A4 metabo... https://johnp887cmw0.eqnextwiki.com/user